Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Lessem

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2016
Ensuring availability of the best tuberculosis treatment options in the PhilippinesErica Lessem, Mike Frick
Nature|February 21, 2014
Russia: Drug-resistant TB can be containedErica Lessem, Salmaan Keshavjee
Health and Human Rights|October 27, 2016
Falling Short of the Rights to Health and Scientific Progress: Inadequate TB Drug Research and AccessMike Frick, Ian Henry, Erica Lessem
The European Respiratory Journal|November 11, 2017
Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosisJennifer Furin, Erica Lessem, Vivian Cox
The Lancet. Respiratory Medicine|September 10, 2017
Bedaquiline or delamanid for rifampin-resistant tuberculosis?Erica Lessem, Vivian Cox, Jennifer Furin
Plos One|September 18, 2020
Public investments in the clinical development of bedaquilineDzintars Gotham, Lindsay McKenna, Mike Frick, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2019
Key features to consider in revising the Model List of Essential In Vitro Diagnostics: a TB perspectiveKhairunisa Suleiman, Kathleen England, Erica Lessem, et al.
The Lancet. Respiratory Medicine|January 17, 2015
Real engagement with communitiesLaia Ruiz Mingote, Wim Vandevelde, Blessina Kumar, et al.
The Lancet. Infectious Diseases|October 14, 2015
Compassionate and optimum use of new tuberculosis drugsCaitlin Reed, Leona Mason, Helen Cox, et al.
Emerging Infectious Diseases|February 18, 2016
Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant TuberculosisJennifer Furin, Grania Brigden, Erica Lessem, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2016
Ensuring availability of the best tuberculosis treatment options in the PhilippinesErica Lessem, Mike Frick
Nature|February 21, 2014
Russia: Drug-resistant TB can be containedErica Lessem, Salmaan Keshavjee
Health and Human Rights|October 27, 2016
Falling Short of the Rights to Health and Scientific Progress: Inadequate TB Drug Research and AccessMike Frick, Ian Henry, Erica Lessem
The European Respiratory Journal|November 11, 2017
Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosisJennifer Furin, Erica Lessem, Vivian Cox
The Lancet. Respiratory Medicine|September 10, 2017
Bedaquiline or delamanid for rifampin-resistant tuberculosis?Erica Lessem, Vivian Cox, Jennifer Furin
Plos One|September 18, 2020
Public investments in the clinical development of bedaquilineDzintars Gotham, Lindsay McKenna, Mike Frick, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2019
Key features to consider in revising the Model List of Essential In Vitro Diagnostics: a TB perspectiveKhairunisa Suleiman, Kathleen England, Erica Lessem, et al.
The Lancet. Respiratory Medicine|January 17, 2015
Real engagement with communitiesLaia Ruiz Mingote, Wim Vandevelde, Blessina Kumar, et al.
The Lancet. Infectious Diseases|October 14, 2015
Compassionate and optimum use of new tuberculosis drugsCaitlin Reed, Leona Mason, Helen Cox, et al.
Emerging Infectious Diseases|February 18, 2016
Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant TuberculosisJennifer Furin, Grania Brigden, Erica Lessem, et al.
Pageof 2